Morgan Stanley analyst Drew Ranieri maintains $Intuitive Surgical (ISRG.US)$ with a hold rating, and adjusts the target price from $475 to $522.
According to TipRanks data, the analyst has a success rate of 38.6% and a total average return of -6.1% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Intuitive Surgical (ISRG.US)$'s main analysts recently are as follows:
Intuitive Surgical's recent quarterly earnings surpassed expectations, signaling a robust period driven by the deployment of the Da Vinci 5 system, significant growth in procedure volumes, and effective margin management. Furthermore, company leadership has revised the forecast for procedure volume growth for the fiscal year upwards, accounting for potential variations in bariatric procedures and the current challenges encountered in Asian markets, particularly due to ongoing physician strikes in Korea.
Expectations appear to be set for a significant revenue outperformance for FY25, as reflected in current market sentiments. Following the company's quarterly financial disclosure, it was observed that there's an approximate 3% increase in the anticipated earnings per share for FY25.
The company has reported robust third-quarter results, exceeding expectations in two key areas - the placement of their DV5 systems and the growth in procedures. Following the U.S. approval of the da Vinci 5, the company is experiencing significant growth momentum. The early adoption of the DV5 is surpassing the initial adoption of its predecessor, indicating a promising potential for accelerated growth as we look towards 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
摩根士丹利分析師Drew Ranieri維持$直覺外科公司 (ISRG.US)$持有評級，並將目標價從475美元上調至522美元。
根據TipRanks數據顯示，該分析師近一年總勝率為38.6%，總平均回報率為-6.1%。
此外，綜合報道，$直覺外科公司 (ISRG.US)$近期主要分析師觀點如下：
Intuitive Surgical最近的季度收益超出了預期，這表明在達芬奇5系統的部署、手術量的顯著增長和有效的利潤管理的推動下，進入了一個強勁的時期。此外，考慮到減肥手術的潛在差異以及亞洲市場當前面臨的挑戰，特別是韓國持續的醫生罷工，公司領導層已經上調了對本財年手術量增長的預測。
正如當前的市場情緒所反映的那樣，預計25財年的收入將大幅跑贏大盤。在公司公佈季度財務披露後，據觀察，25財年的預期每股收益增長了約3％。
該公司公佈了強勁的第三季度業績，在兩個關鍵領域——DV5系統的部署和程序的增長——超出了預期。在美國批准達芬奇5之後，該公司出現了顯著的增長勢頭。DV5的早期採用率超過了其前身的初始採用率，這表明在我們展望2025年時，加速增長的潛力巨大。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
